首页> 外文期刊>Current Cancer Drug Targets >D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.
【24h】

D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.

机译:D-RNAi(Messenger RNA反义DNA干扰)作为针对癌症和病毒感染的新型防御系统。

获取原文
获取原文并翻译 | 示例
           

摘要

D-RNAi (Messenger RNA-antisense DNA interference), a novel posttranscriptional phenomenon of silencing gene expression by transfection of mRNA-aDNA hybrids, was originally observed in the effects of bcl-2 on phorbol ester-induced apoptosis in human prostate cancer LNCaP cells. This phenomenon was also demonstrated in chicken embryos and a human CD4+ T cell line, H9. The in vivo transduction of β-catenin DRNAi was shown to knock out more than 99% endogenous β-catenin gene expression, while the in cell transfection of HIV-1 D-RNAi homolog rejected viral gene replication completely. D-RNAi was found to have long-term gene knockout effects resulting from a posttranscriptional gene silencing mechanism that may involve the homologous recombination between intracellular mRNA and the mRNA components of a D-RNAi construct. These findings provide a potential intracellular defense system against cancer and viral infections.
机译:D-RNAi(信使RNA-反义DNA干扰)是一种通过转染mRNA-aDNA杂种而沉默基因表达的新型转录后现象,最初是在bcl-2对佛波酯诱导的人前列腺癌LNCaP细胞凋亡的影响中观察到的。在鸡胚和人类CD4 + T细胞系H9中也证实了这一现象。研究表明,体内β-cateninDRNAi的转导可敲除99%以上的内源性β-catenin基因表达,而HIV-1 D-RNAi同源物的细胞内转染则完全拒绝了病毒基因的复制。发现D-RNAi具有转录后基因沉默机制,可能涉及细胞内mRNA与D-RNAi构建体的mRNA组分之间的同源重组,从而具有长期的基因敲除作用。这些发现提供了针对癌症和病毒感染的潜在细胞内防御系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号